# Loreto Carmona

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/loreto-carmona/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,866 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 79 |
| i10-index | 266 |
| Last Known Institution | Instituto de Salud Musculoesquelética |
| OpenAlex ID | https://openalex.org/A5001730778 |
| ORCID iD | https://orcid.org/0000-0002-4401-2551 |
| Works | 622 |

## Researcher papers

- [Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010](https://scholariq.org/papers/disability-adjusted-life-years-dalys-for-291-diseases-and-injuries-in-21-regions/)
- [Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010](https://scholariq.org/papers/years-lived-with-disability-ylds-for-1160-sequelae-of-289-diseases-and-injuries/)
- [Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry](https://scholariq.org/papers/characteristics-associated-with-hospitalisation-for-covid-19-in-people-with/)
- [Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry](https://scholariq.org/papers/factors-associated-with-covid-19-related-death-in-people-with-rheumatic-diseases/)
- [The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement](https://scholariq.org/papers/the-risk-of-tuberculosis-related-to-tumour-necrosis-factor-antagonist-therapies/)
- [Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative](https://scholariq.org/papers/multinational-evidence-based-recommendations-for-the-use-of-methotrexate-in/)
- [2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations](https://scholariq.org/papers/2014-update-of-the-eular-standardised-operating-procedures-for-eular-endorsed/)
- [Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative](https://scholariq.org/papers/multinational-evidence-based-recommendations-for-the-diagnosis-and-management-of/)
- [Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry](https://scholariq.org/papers/associations-of-baseline-use-of-biologic-or-targeted-synthetic-dmards-with-covid/)
- [Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study](https://scholariq.org/papers/clinical-outcomes-of-hospitalised-patients-with-covid-19-and-chronic/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Musculoskeletal Disorders and Rehabilitation](https://scholariq.org/topics/musculoskeletal-disorders-and-rehabilitation/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Instituto de Salud Musculoesquelética](https://scholariq.org/institutions/instituto-de-salud-musculoesqueletica/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.